BMRN logo

BioMarin Pharmaceutical Inc. (BMRN) Revenue

Annual revenue:

$2.84B+$419.80M(+17.35%)
December 31, 2024

Summary

  • As of today (September 13, 2025), BMRN annual revenue is $2.84 billion, with the most recent change of +$419.80 million (+17.35%) on December 31, 2024.
  • During the last 3 years, BMRN annual revenue has risen by +$993.13 million (+53.80%).
  • BMRN annual revenue is now at all-time high.

Performance

BMRN Revenue Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBMRNincome statement metrics

Quarterly revenue:

$827.47M+$94.87M(+12.95%)
June 30, 2025

Summary

  • As of today (September 13, 2025), BMRN quarterly revenue is $827.47 million, with the most recent change of +$94.87 million (+12.95%) on June 30, 2025.
  • Over the past year, BMRN quarterly revenue has increased by +$118.81 million (+16.77%).
  • BMRN quarterly revenue is now at all-time high.

Performance

BMRN Quarterly revenue Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBMRNincome statement metrics

TTM revenue:

$3.04B+$118.81M(+4.07%)
June 30, 2025

Summary

  • As of today (September 13, 2025), BMRN TTM revenue is $3.04 billion, with the most recent change of +$118.81 million (+4.07%) on June 30, 2025.
  • Over the past year, BMRN TTM revenue has increased by +$450.19 million (+17.38%).
  • BMRN TTM revenue is now at all-time high.

Performance

BMRN TTM revenue Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBMRNincome statement metrics

BMRN Revenue Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+17.4%+16.8%+17.4%
3 y3 years+53.8%+56.8%+60.5%
5 y5 years+68.4%+96.5%+67.1%

BMRN Revenue Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+53.8%at high+68.8%at high+60.5%
5 y5-yearat high+68.4%at high+102.6%at high+67.1%
alltimeall timeat high>+9999.0%at high>+9999.0%at high>+9999.0%

BMRN Revenue History

DateAnnualQuarterlyTTM
Jun 2025
-
$827.47M(+13.0%)
$3.04B(+4.1%)
Mar 2025
-
$732.60M(-0.8%)
$2.92B(+2.9%)
Dec 2024
$2.84B(+17.4%)
$738.22M(-0.6%)
$2.84B(+3.4%)
Sep 2024
-
$742.38M(+4.8%)
$2.75B(+6.0%)
Jun 2024
-
$708.66M(+9.0%)
$2.59B(+4.6%)
Mar 2024
-
$649.95M(+0.6%)
$2.48B(+2.4%)
Dec 2023
$2.42B(+18.2%)
$645.90M(+10.2%)
$2.42B(+5.7%)
Sep 2023
-
$585.97M(-1.5%)
$2.29B(+4.4%)
Jun 2023
-
$594.60M(+0.3%)
$2.19B(+3.1%)
Mar 2023
-
$592.95M(+15.0%)
$2.13B(+3.9%)
Dec 2022
$2.05B(+10.9%)
$515.78M(+5.2%)
$2.05B(+3.6%)
Sep 2022
-
$490.06M(-7.2%)
$1.98B(+4.3%)
Jun 2022
-
$527.87M(+2.7%)
$1.89B(+1.3%)
Mar 2022
-
$513.79M(+15.6%)
$1.87B(+1.4%)
Dec 2021
$1.85B(+0.2%)
$444.58M(+8.9%)
$1.85B(-0.4%)
Sep 2021
-
$408.34M(-19.0%)
$1.85B(-3.4%)
Jun 2021
-
$504.37M(+3.2%)
$1.92B(+4.5%)
Mar 2021
-
$488.79M(+8.3%)
$1.84B(-0.4%)
Dec 2020
$1.84B(+9.2%)
$451.30M(-4.8%)
$1.84B(+0.2%)
Sep 2020
-
$474.09M(+12.6%)
$1.84B(+1.1%)
Jun 2020
-
$421.21M(-15.0%)
$1.82B(+2.1%)
Mar 2020
-
$495.74M(+10.7%)
$1.78B(+5.7%)
Dec 2019
$1.69B(+12.6%)
$447.94M(-1.5%)
$1.69B(+6.0%)
Sep 2019
-
$454.90M(+18.6%)
$1.59B(+4.5%)
Jun 2019
-
$383.48M(-4.1%)
$1.52B(+0.4%)
Mar 2019
-
$400.05M(+13.5%)
$1.52B(+1.3%)
Dec 2018
$1.50B(+13.5%)
$352.54M(-8.8%)
$1.50B(-0.7%)
Sep 2018
-
$386.68M(+2.6%)
$1.51B(+3.3%)
Jun 2018
-
$376.91M(-1.1%)
$1.46B(+4.3%)
Mar 2018
-
$381.09M(+4.8%)
$1.40B(+6.1%)
Dec 2017
$1.32B(+18.8%)
$363.70M(+7.4%)
$1.32B(+5.1%)
Sep 2017
-
$338.79M(+7.1%)
$1.26B(+5.0%)
Jun 2017
-
$316.33M(+5.4%)
$1.20B(+1.3%)
Mar 2017
-
$300.20M(+0.0%)
$1.18B(+6.0%)
Dec 2016
$1.11B(+27.4%)
$300.09M(+7.8%)
$1.11B(+6.9%)
Sep 2016
-
$278.46M(-7.4%)
$1.04B(+7.7%)
Jun 2016
-
$300.72M(+28.8%)
$966.70M(+6.0%)
Mar 2016
-
$233.55M(+2.5%)
$911.99M(+4.0%)
Dec 2015
$872.18M(+16.3%)
$227.94M(+11.5%)
$876.97M(-0.3%)
Sep 2015
-
$204.49M(-16.9%)
$879.89M(+3.3%)
Jun 2015
-
$246.01M(+23.9%)
$851.68M(+6.7%)
Mar 2015
-
$198.53M(-14.0%)
$798.16M(+6.3%)
Dec 2014
$750.03M(+36.8%)
$230.85M(+31.0%)
$750.87M(+12.4%)
Sep 2014
-
$176.28M(-8.4%)
$667.78M(+6.3%)
Jun 2014
-
$192.50M(+27.3%)
$628.16M(+9.9%)
Mar 2014
-
$151.23M(+2.3%)
$571.75M(+4.3%)
Dec 2013
$548.45M(+10.8%)
$147.76M(+8.1%)
$547.95M(+3.2%)
Sep 2013
-
$136.67M(+0.4%)
$531.21M(+1.6%)
Jun 2013
-
$136.09M(+6.8%)
$522.65M(+2.6%)
Mar 2013
-
$127.43M(-2.7%)
$509.28M(+2.4%)
Dec 2012
$494.89M(+11.0%)
$131.02M(+2.3%)
$497.25M(+4.7%)
Sep 2012
-
$128.12M(+4.4%)
$474.86M(+2.8%)
Jun 2012
-
$122.71M(+6.3%)
$461.91M(+2.2%)
Mar 2012
-
$115.40M(+6.2%)
$451.82M(+1.4%)
DateAnnualQuarterlyTTM
Dec 2011
$446.00M(+20.0%)
$108.63M(-5.7%)
$445.55M(+1.6%)
Sep 2011
-
$115.17M(+2.3%)
$438.54M(+4.1%)
Jun 2011
-
$112.63M(+3.2%)
$421.12M(+5.2%)
Mar 2011
-
$109.13M(+7.4%)
$400.44M(+6.4%)
Dec 2010
$371.58M(+14.4%)
$101.61M(+4.0%)
$376.27M(+4.0%)
Sep 2010
-
$97.75M(+6.3%)
$361.73M(+4.7%)
Jun 2010
-
$91.95M(+8.2%)
$345.52M(+2.7%)
Mar 2010
-
$84.95M(-2.4%)
$336.36M(+3.4%)
Dec 2009
$324.72M(+9.5%)
$87.08M(+6.8%)
$325.39M(-3.6%)
Sep 2009
-
$81.54M(-1.5%)
$337.58M(+2.7%)
Jun 2009
-
$82.79M(+11.9%)
$328.69M(+6.0%)
Mar 2009
-
$73.98M(-25.5%)
$310.08M(+4.6%)
Dec 2008
$296.49M(+143.9%)
$99.28M(+36.7%)
$296.49M(+22.5%)
Sep 2008
-
$72.65M(+13.2%)
$242.07M(+24.5%)
Jun 2008
-
$64.17M(+6.3%)
$194.43M(+22.2%)
Mar 2008
-
$60.40M(+34.7%)
$159.14M(+30.9%)
Dec 2007
$121.58M(+44.4%)
$44.85M(+79.4%)
$121.58M(+23.1%)
Sep 2007
-
$25.01M(-13.4%)
$98.75M(+0.1%)
Jun 2007
-
$28.88M(+26.5%)
$98.67M(+5.8%)
Mar 2007
-
$22.84M(+3.7%)
$93.23M(+10.7%)
Dec 2006
$84.21M(+228.1%)
$22.02M(-11.7%)
$84.21M(+17.5%)
Sep 2006
-
$24.93M(+6.3%)
$71.66M(+31.9%)
Jun 2006
-
$23.45M(+69.8%)
$54.31M(+57.5%)
Mar 2006
-
$13.81M(+45.8%)
$34.49M(+34.4%)
Dec 2005
$25.67M(+37.7%)
$9.47M(+25.0%)
$25.67M(-14.7%)
Sep 2005
-
$7.58M(+109.0%)
$30.09M(+32.6%)
Jun 2005
-
$3.63M(-27.3%)
$22.69M(-4.0%)
Mar 2005
-
$4.99M(-64.1%)
$23.63M(+26.8%)
Dec 2004
$18.64M(>+9900.0%)
$13.90M(+7577.9%)
$18.64M(+292.9%)
Sep 2004
-
$181.00K(-96.0%)
$4.74M(+4.0%)
Jun 2004
-
$4.56M(>+9900.0%)
$4.56M(-62.3%)
Mar 2004
-
$0.00(0.0%)
$12.10M(-22.4%)
Dec 2003
$0.00(-100.0%)
$0.00(0.0%)
$15.60M(-16.7%)
Sep 2003
-
$0.00(-100.0%)
$18.73M(-16.0%)
Jun 2003
-
$12.10M(+246.1%)
$22.30M(+63.7%)
Mar 2003
-
$3.50M(+11.5%)
$13.62M(-2.1%)
Dec 2002
$13.92M(+19.0%)
$3.13M(-12.2%)
$13.92M(+1.7%)
Sep 2002
-
$3.57M(+4.3%)
$13.68M(-1.3%)
Jun 2002
-
$3.42M(-9.7%)
$13.86M(-1.7%)
Mar 2002
-
$3.79M(+30.9%)
$14.10M(+2.9%)
Dec 2001
$11.70M(-5.1%)
$2.90M(-22.6%)
$13.70M(-1.7%)
Sep 2001
-
$3.74M(+2.2%)
$13.95M(+7.2%)
Jun 2001
-
$3.66M(+7.8%)
$13.01M(+4.7%)
Mar 2001
-
$3.40M(+8.3%)
$12.43M(+0.8%)
Dec 2000
$12.33M(+76.7%)
$3.14M(+11.8%)
$12.33M(+7.2%)
Sep 2000
-
$2.81M(-9.0%)
$11.50M(+7.6%)
Jun 2000
-
$3.08M(-6.5%)
$10.70M(+22.0%)
Mar 2000
-
$3.30M(+42.5%)
$8.77M(+33.4%)
Dec 1999
$6.98M(+486.0%)
$2.31M(+15.8%)
$6.58M(+54.3%)
Sep 1999
-
$2.00M(+72.7%)
$4.26M(+88.4%)
Jun 1999
-
$1.16M(+4.8%)
$2.26M(+104.8%)
Mar 1999
-
$1.10M
$1.10M
Dec 1998
$1.19M(>+9900.0%)
-
-
Dec 1997
$0.00
-
-

FAQ

  • What is BioMarin Pharmaceutical Inc. annual revenue?
  • What is the all time high annual revenue for BioMarin Pharmaceutical Inc.?
  • What is BioMarin Pharmaceutical Inc. annual revenue year-on-year change?
  • What is BioMarin Pharmaceutical Inc. quarterly revenue?
  • What is the all time high quarterly revenue for BioMarin Pharmaceutical Inc.?
  • What is BioMarin Pharmaceutical Inc. quarterly revenue year-on-year change?
  • What is BioMarin Pharmaceutical Inc. TTM revenue?
  • What is the all time high TTM revenue for BioMarin Pharmaceutical Inc.?
  • What is BioMarin Pharmaceutical Inc. TTM revenue year-on-year change?

What is BioMarin Pharmaceutical Inc. annual revenue?

The current annual revenue of BMRN is $2.84B

What is the all time high annual revenue for BioMarin Pharmaceutical Inc.?

BioMarin Pharmaceutical Inc. all-time high annual revenue is $2.84B

What is BioMarin Pharmaceutical Inc. annual revenue year-on-year change?

Over the past year, BMRN annual revenue has changed by +$419.80M (+17.35%)

What is BioMarin Pharmaceutical Inc. quarterly revenue?

The current quarterly revenue of BMRN is $827.47M

What is the all time high quarterly revenue for BioMarin Pharmaceutical Inc.?

BioMarin Pharmaceutical Inc. all-time high quarterly revenue is $827.47M

What is BioMarin Pharmaceutical Inc. quarterly revenue year-on-year change?

Over the past year, BMRN quarterly revenue has changed by +$118.81M (+16.77%)

What is BioMarin Pharmaceutical Inc. TTM revenue?

The current TTM revenue of BMRN is $3.04B

What is the all time high TTM revenue for BioMarin Pharmaceutical Inc.?

BioMarin Pharmaceutical Inc. all-time high TTM revenue is $3.04B

What is BioMarin Pharmaceutical Inc. TTM revenue year-on-year change?

Over the past year, BMRN TTM revenue has changed by +$450.19M (+17.38%)
On this page